netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

Chapter Links...
 Details...
03.02  Expand sub section  Corticosteroids
 note  Patients established on inhaler devices not on the formulary only to be switched to an alternative device if part of a formal clinical review
Beclometasone dipropionate aerosol inhalers, breath actuated inhalers (Clenil modulite and Qvar products)
View adult BNF View SPC online
Formulary
Green

Beclometasone diproprionate aerosol inhalers should be prescribed by brand name

Different brands are not dose equivalent

 
   
Beclometasone propionate dry powder inhaler (Easyhaler beclometasone®)
View adult BNF View SPC online
Formulary
Green

 
   
Budesonide nebuliser solution
View adult BNF View SPC online
Formulary  
   
03.02.01  Expand sub section  Inhaled Corticosteroids
Alvesco® aerosol powder inhaler (ciclesonide)
View adult BNF View SPC online
Restricted Drug Restricted
Amber 2

Specialist recommendation only

For control of asthma in adults who acquire repeated oropharyngeal candidiasis and/or hoarsness from other inhaled carticosteroids

 
   
03.02.02  Expand sub section  Combination products (ICS+LABA) for asthma
Flutiform® aerosol inhaler (fluticasone propionate and formoterol)
View adult BNF View SPC online
Restricted Drug Restricted
Amber 1

Restricted to use in asthma where high strength inhaled corticosteroids are required

 
   
Fostair NEXThaler® 100/6 micrograms dry powder inhaler (beclometasone diopropionate and formoterol - asthma)
View adult BNF View SPC online
Formulary
Green

 
   
Fostair NEXThaler® 200/6 micrograms dry powder inhaler (beclometasone diopropionate and formoterol - asthma)
View adult BNF View SPC online
Formulary
Amber 1

 
   
Fostair® 100/6 micrograms aerosol inhaler (beclometasone diopropionate and formoterol - asthma)
View adult BNF View SPC online
Formulary
Green

 
   
Fostair® 200/6 micrograms aerosol inhaler (beclometasone diopropionate and formoterol - asthma)
View adult BNF View SPC online
Formulary
Amber 1

 
   
Relvar Ellipta® 92/22 micrograms dry powder inhlaer (fluticasone furoate and vilaterol - asthma)
View adult BNF View SPC online
Formulary
Green

 
   
Relvar Ellipta® 184/22 micrograms dry powder inhlaer (fluticasone furoate and vilaterol - asthma)
View adult BNF View SPC online
Formulary
Amber 1

 

 
   
03.02.03  Expand sub section  Combination products (ICS+LABA) for COPD
Fostair NEXThaler® 100/6 micrograms dry powder inhaler (beclometasone dipropionate and formoterol - COPD)
View adult BNF View SPC online
Formulary
Green

Only 100/6 micrograms strength is licensed for COPD

 
   
Fostair® 100/6 micrograms aerosol inhaler (beclometasone diopropionate and formoterol - COPD)
View adult BNF View SPC online
Formulary
Green

Only 100/6 micrograms strength is licensed for COPD

 
   
Relvar Ellipta® 92/22 micrograms dry powder inhlaer (fluticasone furoate and vilaterol - asthma)
View adult BNF View SPC online
Formulary
Green

Only 92/22 micrograms strength is licensed for COPD

 
   
Trelegy® Ellipta® inhaler device (fluticasone furoate and vilanterol umeclidinium bromide)
View adult BNF View SPC online
Formulary
Amber 1

 
Link  SEL APC recommendation: Triple combination therapy inhalers for adults with chronic obstructive pulmonary disease (COPD): Trelegy® Ellipta®
   
Trimbow® inhaler device (beclometasone dipropionate and formoterol fumarate dihydrate and glycopyrronium)
View adult BNF View SPC online
Formulary
Amber 1

 
Link  Triple combination therapy inhalers for adults with chronic obstructive pulmonary disease (COPD): Trimbow®
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary